0001104659-22-080842.txt : 20220719 0001104659-22-080842.hdr.sgml : 20220719 20220719160537 ACCESSION NUMBER: 0001104659-22-080842 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220719 FILED AS OF DATE: 20220719 DATE AS OF CHANGE: 20220719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quipt Home Medical Corp. CENTRAL INDEX KEY: 0001540013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40413 FILM NUMBER: 221091617 BUSINESS ADDRESS: STREET 1: 1019 TOWN DRIVE CITY: WILDER STATE: KY ZIP: 41076 BUSINESS PHONE: 859-878-2220 MAIL ADDRESS: STREET 1: 1019 TOWN DRIVE CITY: WILDER STATE: KY ZIP: 41076 FORMER COMPANY: FORMER CONFORMED NAME: Protech Home Medical Corp. DATE OF NAME CHANGE: 20200714 FORMER COMPANY: FORMER CONFORMED NAME: Patient Home Monitoring Corp. DATE OF NAME CHANGE: 20120119 6-K 1 tm2221396d1_6k.htm FORM 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2022

 

Commission File Number: 001-40413

 

 

Quipt Home Medical Corp.

(Translation of registrant’s name into English)

 

 

1019 Town Drive

Wilder, Kentucky 41076

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ¨                Form 40-F  x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit   Description
   
99.1   News Release dated July 19, 2022

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Quipt Home Medical Corp.
   
Date: July 19, 2022 /s/ Gregory Crawford
  Chief Executive Officer

 

 

 

 

 EX-99.1 2 tm2221396d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

QUIPT HOME MEDICAL TO PARTICIPATE AT THE 42nd ANNUAL CANACCORD GROWTH
CONFERENCE ON AUGUST 8TH - 11TH

 

WEBCASTED PRESENTATION TO BE HELD THURSDAY AUGUST 11TH

 

Cincinnati, Ohio – July 19, 2022 – Quipt Home Medical Corp. (the “Company” or “Quipt”) (NASDAQ: QIPT), (TSXV: QIPT) a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that members of its management team will host a webcasted presentation and participate in 1x1 meetings at the 42nd Annual Canaccord Growth Conference on August 8th – 11th. The conference will be held in person at the InterContinental Boston.

 

Webcasted Presentation

 

Event:   Canaccord 42nd Annual Growth Conference
Date:     Thursday, August 11, 2022
Time:    2:00pm ET

 

The live webcast of the presentation will be available by visiting the investors' section of the Company's website at www.quipthomemedical.com. The webcast will also be available for replay on the Company's website following the event.

 

ABOUT QUIPT HOME MEDICAL

 

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of ‎the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.‎

 

For further information please visit our website at www.Quipthomemedical.com, or contact:

 

Cole Stevens

VP of Corporate Development

Quipt Home Medical Corp.

859-300-6455

cole.stevens@myquipt.com

 

Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
859-300-6455
investorinfo@myquipt.com